Open Stage Seminar Oct. 13 (Fri.) ,2017 13:10-13:20

【Company Presentations】

Nikon CeLL innovation


Toshiyuki Nakayama


CDMO Facility Introduction of Nikon CeLL innovation Co., Ltd.

Nikon CeLL innovation Co. Ltd.(NCLi) announced an exclusive collaboration in 2015 with Lonza, a leader in pharmaceutical and biotech contract manufacturing, in order to establish a strong footprint in the Japanese regenerative medicine market. NCLi’s primary mission is the prompt establishment of a reliable contract development and manufacturing infrastructure for cell and gene therapies. NCLi offers a broad selection of contract development and manufacturing services for early- to late-phase clinical and commercial cell and gene therapy products compliant to GCTP/cGMP. Update the status of NCLi.